AI Matters

Why it matters

Anthropic launches drug discovery program for neglected diseases

The Decoder Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable

Anthropic has launched its own drug development program targeting neglected diseases that traditional pharmaceutical companies find unprofitable. The initiative aims to leverage AI to significantly reduce development timelines and improve clinical success rates.

Why it matters

It could accelerate treatments for unprofitable diseases, potentially cutting development times and doubling success rates.